| Nov 15 |
CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia
|
| Nov 11 |
Crude Oil Down 3%; Aramark Posts Upbeat Earnings
|
| Nov 11 |
CERo Therapeutics Stock Is Soaring Monday: What's Going On?
|
| Nov 11 |
CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity
|
| Oct 21 |
CERo Therapeutics files to sell 713.6M shares of common stock for holders
|
| Oct 21 |
CERo Therapeutics, Inc. Provides Corporate Update
|
| Oct 2 |
CERo Therapeutics gets new finance head
|
| Oct 2 |
CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer
|
| Sep 25 |
Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump
|
| Sep 25 |
CERo Therapeutics says CEO Atwood, CFO Carter to step down
|
